Imunon, Inc. Balance Sheet
IMNN|7 years of annual SEC 10-K data (FY2015-FY2023)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Imunon, Inc. had $22M in total assets and $29M in shareholders' equity as of FY2023.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2015 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.8M | $11.5M | $19.6M | $17.2M | $6.9M | $13.4M | $12.7M |
| Accounts Receivable | $0 | $0 | - | - | - | - | - |
| Current Assets | $18.2M | $37.2M | $51.9M | $18.8M | $16.2M | $28.1M | $20.3M |
| PP&E (Net) | $751.9K | $548.3K | $477.0K | $294.6K | $405.4K | $184.6K | $854.9K |
| Goodwill | - | - | - | $2.0M | $2.0M | $2.0M | $2.0M |
| Total Assets | $21.9M | $44.0M | $74.0M | $37.5M | $38.3M | $46.9M | $49.1M |
| Current Liabilities | $7.4M | $10.0M | $6.8M | $6.8M | $7.9M | $6.1M | $9.3M |
| Shareholders' Equity | $29.3M | $55.8M | $18.6M | $14.6M | $20.9M | $26.7M | $32.8M |